<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>5</volume><submitter>Xie X</submitter><pubmed_abstract>MicroRNA (miRNA) studies are experiencing a transition from basic research applications to clinical applications. However, the lack of reliable and sensitive miRNA detection methods has become a bottleneck in the process. Here, we report an absolute quantification method based on the competitive PCR amplification of specific miRNAs and synthetic RNA spike-ins in a single reaction. RNA spike-ins are quantified as dynamic RNA copy number standards and are used to measure selected miRNAs free from the effects of intra-assay variables, including those from individual sample sources. Combined with the size differentiation power of capillary electrophoresis, the content of miRNAs was reproducibly measured, with verifiable detection limits of 10-46 copies over 5-log detection ranges. The direct measurements of miRNAs from 168 human serum samples and their considerable value as a diagnostic for bronchopneumonia and bronchiolitis demonstrate the potential of the assay in clinical applications.</pubmed_abstract><journal>Scientific reports</journal><pagination>9356</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4366852</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>MicroRNA-derived fragment length polymorphism assay.</pubmed_title><pmcid>PMC4366852</pmcid><pubmed_authors>Zhang F</pubmed_authors><pubmed_authors>Xu K</pubmed_authors><pubmed_authors>Yang Z</pubmed_authors><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Feng Z</pubmed_authors><pubmed_authors>Zhu J</pubmed_authors><pubmed_authors>Xie X</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Tang F</pubmed_authors><pubmed_authors>Wu X</pubmed_authors></additional><is_claimable>false</is_claimable><name>MicroRNA-derived fragment length polymorphism assay.</name><description>MicroRNA (miRNA) studies are experiencing a transition from basic research applications to clinical applications. However, the lack of reliable and sensitive miRNA detection methods has become a bottleneck in the process. Here, we report an absolute quantification method based on the competitive PCR amplification of specific miRNAs and synthetic RNA spike-ins in a single reaction. RNA spike-ins are quantified as dynamic RNA copy number standards and are used to measure selected miRNAs free from the effects of intra-assay variables, including those from individual sample sources. Combined with the size differentiation power of capillary electrophoresis, the content of miRNAs was reproducibly measured, with verifiable detection limits of 10-46 copies over 5-log detection ranges. The direct measurements of miRNAs from 168 human serum samples and their considerable value as a diagnostic for bronchopneumonia and bronchiolitis demonstrate the potential of the assay in clinical applications.</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Mar</publication><modification>2026-05-03T06:51:18.581Z</modification><creation>2026-04-07T18:57:40.543Z</creation></dates><accession>S-EPMC4366852</accession><cross_references><pubmed>25790971</pubmed><doi>10.1038/srep09356</doi></cross_references></HashMap>